bluebird bio
BLUE
#9767
Rank
HK$0.37 B
Marketcap
HK$38.68
Share price
0.00%
Change (1 day)
-75.59%
Change (1 year)

Market capitalization of bluebird bio (BLUE)

Last known market cap: HK$0.37 Billion

As of January 2026 bluebird bio has a market cap of HK$0.37 Billion. This makes bluebird bio the world's 9767th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of bluebird bio from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$0.37 B-39.86%
2024HK$0.62 B-69.68%
2023HK$2.07 B-53.66%
2022HK$4.48 B-17.92%
2021HK$5.46 B-75.47%
2020HK$22.26 B-41.16%
2019HK$37.83 B-11.01%
2018HK$42.52 B-37.73%
2017HK$68.28 B282.59%
2016HK$17.84 B-2.81%
2015HK$18.36 B-20.18%
2014HK$23.00 B490.74%
2013HK$3.89 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
HK$88.85 B 23,359.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
HK$85.07 B 22,361.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$913.75 B 241,139.87%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
HK$1.09 B 190.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.046 T 540,119.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
HK$78.85 M-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA